Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aharon Kessel

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 6, 2025
Lanadelumab's impact on hereditary angioedema control and quality of life across disease activity subgroups: Real-world evidenceAndrea Zanichelli, Walter A Wuillemin, Emel Aygören-Pürsün, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
The Lancet. Haematology|March 22, 2026
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trialMarcus Maurer, Marcin Stobiecki, Anna Valerieva, et al.
The World Allergy Organization Journal|June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trialsEmel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
Allergy|September 18, 2021
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticariaTorsten Zuberbier, Amir Hamzah Abdul Latiff, Mohamed Abuzakouk, et al.
The World Allergy Organization Journal|May 21, 2026
The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparitiesDaniel O Vázquez, Pedro Giavina-Bianchi, Darío Josviack, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 6, 2025
Lanadelumab's impact on hereditary angioedema control and quality of life across disease activity subgroups: Real-world evidenceAndrea Zanichelli, Walter A Wuillemin, Emel Aygören-Pürsün, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
The Lancet. Haematology|March 22, 2026
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trialMarcus Maurer, Marcin Stobiecki, Anna Valerieva, et al.
The World Allergy Organization Journal|June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trialsEmel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
Allergy|September 18, 2021
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticariaTorsten Zuberbier, Amir Hamzah Abdul Latiff, Mohamed Abuzakouk, et al.
The World Allergy Organization Journal|May 21, 2026
The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparitiesDaniel O Vázquez, Pedro Giavina-Bianchi, Darío Josviack, et al.
Pageof 9